Most Popular

Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury Results of a ground-breaking clinical trial on ibogaine-magnesium therapy for Special Operations Veterans (SOV) with repeated blast exposure have been published in the journal Nature. These outcomes are highly anticipated, providing crucial proof of …

Read more

It’s a new year, the ideal time to start investing. Compounding does its best work late, and the earlier you start, the more wealth you’ll build over time. One of investing’s beautiful facets is that the stock market welcomes everyone. Whether you’re affluent or starting …

Read more

Big-spending investors have taken a bearish stance on Cytokinetics CYTK. This isn’t normal. The overall sentiment of these big-money traders is split between 37% bullish and 62%, bearish. Out of all of the special options we uncovered, 9 are puts, for a total amount of …

Read more

Tesla Inc TSLA CEO Elon Musk hinted at a broader product lineup, dwarfing the current offerings of the EV giant on Friday, leaving enthusiasts and investors alike in eager anticipation of what could be in store. Mysterious Tease What Happened: Musk’s enigmatic response to a post by …

Read more

As the Federal Reserve predicts a 51.84% chance of a recession within the next year, the specter of an economic downturn looms large in the minds of investors. This probability, though seemingly modest at first blush, holds considerable weight given historical trends, rendering it the …

Read more

How far from the Big Blue tree did the Kyndryl (NYSE: KD) apple fall? Formerly known as IBM‘s (NYSE: IBM) IT infrastructure-services division, Kyndryl spun out as an independent public company in 2021. As a separate business, Kyndryl is the world’s largest provider of support …

Read more

As we reset our financial compass for another cycle around the sun, it’s an opportune moment for investors to mull over their past decisions and refocus their investment strategies. Those aiming to inject fresh funds into their investment accounts are on the hunt for robust …

Read more

Palantir Technologies, Inc. PLTR shares pulled back on Friday after an analyst downgraded the stock, and Cathie Wood’s Ark Invest used the weakness as a buying opportunity. Ark Invest Amplifies Palantir Stake Amid Analyst Downgrade Ark Invest’s flagship exchange-traded fund, the Ark Innovation ETF ARKK …

Read more

Ford Motor Company (NYSE: F) just released its fourth-quarter sales data for investors to chew on before the company releases its fourth-quarter and full-year 2023 results later this month. The good news is that the company posted a record quarter for electric vehicle (EV) sales, …

Read more

A decade after its founding as a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS),lykos Public Benefit Corporation has triumphantly secured over $100 million in a Series A private stock sale. This immense infusion of funds will underpin the final stages of its …

Read more